24 May 2013
Keywords: fda, fast-track, gtc, atryn, biotherapeutics, says, food
Article | 10 September 2007
GTC Biotherapeutics says that the US Food and Drug Administration has designated its recombinant form of human antithrombin, ATryn, a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 September 2007
17 September 2007
23 May 2013
© 2013 thepharmaletter.com